These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 6056258)

  • 21. Drug-resistant pulmonary tuberculosis in Norway. Preliminary report.
    Bjartveit K
    Scand J Respir Dis Suppl; 1969; 69():21-2. PubMed ID: 5264216
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited PAS administration. I. Methods and results].
    Stopczyk J; Niemirowska H; Pecyna-Sielewicz J; Janowiec M; Banaszkiewicz H; Czerwiński Z; Królikowska H; Krahowska M; Malecki S; Pezińska Z; Pilch Z; Przemyska B; Szustrowa I; Wardowa A
    Gruzlica; 1973 Jul; 41(7):755-64. PubMed ID: 4730976
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of classical chemotherapy in in-patient and out-patient treatment of freshly detected pulmonary tuberculosis].
    Kuczborski S
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):339-41. PubMed ID: 5897864
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibacterial therapy of pulmonary tuberculosis in the Bulgarian People's Republic and possibilities of its improvement].
    Dimitrov DA
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):342-3. PubMed ID: 5897865
    [No Abstract]   [Full Text] [Related]  

  • 27. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 28. Trial of sanatorium treatment including a comparison of standard and intermittent continuation chemotherapy: Central Bohemian Tuberculosis Services-WHO-British Medical Research Council investigation.
    Polansky F
    Bull Int Union Tuberc; 1970 Jun; 43():295-302. PubMed ID: 5425558
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical significance of the resistance to the classical tuberculostatics].
    Eule H
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):319-24. PubMed ID: 5897859
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M
    Pol Med J; 1967; 6(3):604-9. PubMed ID: 6038083
    [No Abstract]   [Full Text] [Related]  

  • 31. [The four-fold treatment of serious forms of pulmonary tuberculosis].
    Amsler R
    Sem Ther; 1966; 42(6):365-6. PubMed ID: 5984624
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness and problems of the treatment of tuberculosis under the environmental conditions of an underdeveloped country].
    Henneghien C; Ballez C; Horvath K; el-Fassi M
    Acta Tuberc Pneumol Belg; 1969; 60(6):821-32. PubMed ID: 5397018
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative data on the study of single and fractional use of antitubercular agents of the first order in the treatment of tuberculosis in children and adolescents].
    Firsova VA; Kupish SG; Ivanova AI; Maslauskene TP; Novruzov MA
    Vopr Okhr Materin Det; 1976; 21(3):52-4. PubMed ID: 1086033
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Ugeskr Laeger; 1973 Aug; 135(34):1795-9. PubMed ID: 4592618
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O; Brander L
    Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
    [No Abstract]   [Full Text] [Related]  

  • 36. [Liver function during tuberculosis therapy with streptomycin, isoniazid and aminosalicylate].
    Aamodt T
    Nord Med; 1970 Jun; 83(24):774. PubMed ID: 5426083
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 38. [Organization and effectiveness of the treatment of patients with newly detected destructive pulmonary tuberculosis].
    Beĭda MM; Dummich IuA; Shimko EP; Pashchenko SI; Donchenko VL
    Sov Med; 1973 Oct; 36(10):150. PubMed ID: 4789206
    [No Abstract]   [Full Text] [Related]  

  • 39. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
    Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
    Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
    [No Abstract]   [Full Text] [Related]  

  • 40. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.